| CACNA1A; calcium channel, voltage-dependent, P/Q type, alpha 1A subunit [KO: K04344] |
| CACNA1B; calcium channel, voltage-dependent, N type, alpha 1B subunit [KO: K04849] |
| CACNA1C; calcium channel, voltage-dependent, L type, alpha 1C subunit [KO: K04850] |
| CACNA1D; calcium channel, voltage-dependent, L type, alpha 1D subunit [KO: K04851] |
| CACNA1E; calcium channel, voltage-dependent, R type, alpha 1E subunit [KO: K04852] |
| CACNA1F; calcium channel, voltage-dependent, L type, alpha 1F subunit [KO: K04853] |
| voltage-dependent L-type calcium channel subunit alpha-1F-like; K04853 voltage-dependent calcium channel L type alpha-1F [KO: K04853] |
| CACNA1G; calcium channel, voltage-dependent, T type, alpha 1G subunit [KO: K04854] |
| CACNA1H; calcium channel, voltage-dependent, T type, alpha 1H subunit [KO: K04855] |
| CACNA1I; calcium channel, voltage-dependent, T type, alpha 1I subunit [KO: K04856] |
| CACNA1S; calcium channel, voltage-dependent, L type, alpha 1S subunit [KO: K04857] |
| CACNA2D1; calcium channel, voltage-dependent, alpha 2/delta subunit 1 [KO: K04858] |
| CACNA2D2; calcium channel, voltage-dependent, alpha 2/delta subunit 2 [KO: K04859] |
| CACNA2D3; calcium channel, voltage-dependent, alpha 2/delta subunit 3 [KO: K04860] |
| CACNA2D4; calcium channel, voltage-dependent, alpha 2/delta subunit 4 [KO: K04861] |
| CACNB1; calcium channel, voltage-dependent, beta 1 subunit [KO: K04862] |
| CACNB2; calcium channel, voltage-dependent, beta 2 subunit [KO: K04863] |
| CACNB3; calcium channel, voltage-dependent, beta 3 subunit [KO: K04864] |
| CACNB4; calcium channel, voltage-dependent, beta 4 subunit [KO: K04865] |
| CACNG1; calcium channel, voltage-dependent, gamma subunit 1 [KO: K04866] |
| CACNG2; calcium channel, voltage-dependent, gamma subunit 2 [KO: K04867] |
| CACNG3; calcium channel, voltage-dependent, gamma subunit 3 [KO: K04868] |
| CACNG4; calcium channel, voltage-dependent, gamma subunit 4 [KO: K04869] |
| CACNG5; calcium channel, voltage-dependent, gamma subunit 5 [KO: K04870] |
| CACNG6; calcium channel, voltage-dependent, gamma subunit 6 [KO: K04871] |
| CACNG7; calcium channel, voltage-dependent, gamma subunit 7 [KO: K04872] |
| CACNG8; calcium channel, voltage-dependent, gamma subunit 8 [KO: K04873] |
| PRKACB; protein kinase, cAMP-dependent, catalytic, beta [KO: K04345] [EC: 2.7.11.11] |
| PRKACG; protein kinase, cAMP-dependent, catalytic, gamma [KO: K04345] [EC: 2.7.11.11] |
| |
| PRKACA; protein kinase, cAMP-dependent, catalytic, alpha [KO: K04345] [EC: 2.7.11.11] |
| cAMP-dependent protein kinase catalytic subunit PRKX-like; K04345 protein kinase A [EC: 2.7.11.11] [KO: K04345] [EC: 2.7.11.11] |
| |
| |
| |
| GNA12; guanine nucleotide binding protein (G protein) alpha 12 [KO: K04346] |
| GNG12; guanine nucleotide binding protein (G protein), gamma 12 [KO: K04347] |
| guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7-like; K04347 guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 [KO: K04347] |
| PPP3CC; protein phosphatase 3, catalytic subunit, gamma isozyme [KO: K04348] [EC: 3.1.3.16] |
| PPP3CA; protein phosphatase 3, catalytic subunit, alpha isozyme [KO: K04348] [EC: 3.1.3.16] |
| PPP3CB; protein phosphatase 3, catalytic subunit, beta isozyme [KO: K04348] [EC: 3.1.3.16] |
| PPP3R2; protein phosphatase 3, regulatory subunit B, beta [KO: K06268] |
| CHP1; calcineurin-like EF hand protein 1 [KO: K06268] |
| CHP2; calcineurin-like EF hand protein 2 [KO: K06268] |
| PPP3R1; protein phosphatase 3, regulatory subunit B, alpha [KO: K06268] |
| RASGRF1; Ras protein-specific guanine nucleotide-releasing factor 1 [KO: K04349] |
| RASGRF2; Ras protein-specific guanine nucleotide-releasing factor 2 [KO: K12326] |
| RASGRP1; RAS guanyl releasing protein 1 (calcium and DAG-regulated) [KO: K04350] |
| RASGRP2; RAS guanyl releasing protein 2 (calcium and DAG-regulated) [KO: K12361] |
| RASGRP3; RAS guanyl releasing protein 3 (calcium and DAG-regulated) [KO: K12362] |
| RASGRP4; RAS guanyl releasing protein 4 [KO: K12363] |
| RAPGEF2; Rap guanine nucleotide exchange factor (GEF) 2 [KO: K08018] |
| NF1; neurofibromin 1 [KO: K08052] |
| RASA1; RAS p21 protein activator (GTPase activating protein) 1 [KO: K04352] |
| RASA2; RAS p21 protein activator 2 [KO: K08053] |
| RAP1A; RAP1A, member of RAS oncogene family [KO: K04353] |
| RAP1B; RAP1B, member of RAS oncogene family [KO: K07836] |
| NGF; nerve growth factor (beta polypeptide) [KO: K02582] |
| BDNF; brain-derived neurotrophic factor [KO: K04355] |
| NTF3; neurotrophin 3 [KO: K04356] |
| NTF4; neurotrophin 4 [KO: K12457] |
| EGF; epidermal growth factor [KO: K04357] |
| FGF6; fibroblast growth factor 6 [KO: K04358] |
| FGF23; fibroblast growth factor 23 [KO: K04358] |
| FGF12; fibroblast growth factor 12 [KO: K04358] |
| FGF21; fibroblast growth factor 21 [KO: K04358] |
| FGF17; fibroblast growth factor 17 [KO: K04358] |
| FGF10; fibroblast growth factor 10 [KO: K04358] |
| FGF13; fibroblast growth factor 13 [KO: K04358] |
| FGF22; fibroblast growth factor 22 [KO: K04358] |
| FGF1; fibroblast growth factor 1 (acidic) [KO: K04358] |
| FGF7; fibroblast growth factor 7 [KO: K04358] |
| FGF16; fibroblast growth factor 16 [KO: K04358] |
| FGF5; fibroblast growth factor 5 [KO: K04358] |
| FGF11; fibroblast growth factor 11 [KO: K04358] |
| FGF18; fibroblast growth factor 18 [KO: K04358] |
| FGF4; fibroblast growth factor 4 [KO: K04358] |
| FGF3; fibroblast growth factor 3 [KO: K04358] |
| FGF20; fibroblast growth factor 20 [KO: K04358] |
| FGF14; fibroblast growth factor 14 [KO: K04358] |
| FGF9; fibroblast growth factor 9 (glia-activating factor) [KO: K04358] |
| FGF2; fibroblast growth factor 2 (basic) [KO: K04358] |
| FGF8; fibroblast growth factor 8 (androgen-induced) [KO: K04358] |
| FGF19; fibroblast growth factor 19 [KO: K04358] |
| PDGFB; platelet-derived growth factor beta polypeptide [KO: K04359] |
| PDGFA; platelet-derived growth factor alpha polypeptide [KO: K04359] |
| NTRK1; neurotrophic tyrosine kinase, receptor, type 1 [KO: K03176] [EC: 2.7.10.1] |
| NTRK2; neurotrophic tyrosine kinase, receptor, type 2 [KO: K04360] [EC: 2.7.10.1] |
| |
| |
| |
| |
| |
| PDGFRA; platelet-derived growth factor receptor, alpha polypeptide [KO: K04363] [EC: 2.7.10.1] |
| PDGFRB; platelet-derived growth factor receptor, beta polypeptide [KO: K05089] [EC: 2.7.10.1] |
| GRB2; growth factor receptor-bound protein 2 [KO: K04364] |
| SOS1; son of sevenless homolog 1 (Drosophila) [KO: K03099] |
| SOS2; son of sevenless homolog 2 (Drosophila) [KO: K03099] |
| HRAS; v-Ha-ras Harvey rat sarcoma viral oncogene homolog [KO: K02833] |
| KRAS; v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog [KO: K07827] |
| NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO: K07828] |
| RRAS; related RAS viral (r-ras) oncogene homolog [KO: K07829] |
| RRAS2; related RAS viral (r-ras) oncogene homolog 2 [KO: K07830] |
| MRAS; muscle RAS oncogene homolog [KO: K07831] |
| BRAF; v-raf murine sarcoma viral oncogene homolog B1 [KO: K04365] [EC: 2.7.11.1] |
| RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 [KO: K04366] [EC: 2.7.11.1] |
| MOS; v-mos Moloney murine sarcoma viral oncogene homolog [KO: K04367] [EC: 2.7.11.1] |
| MAP2K1; mitogen-activated protein kinase kinase 1 [KO: K04368] [EC: 2.7.12.2] |
| MAP2K2; mitogen-activated protein kinase kinase 2 [KO: K04369] [EC: 2.7.12.2] |
| dual specificity mitogen-activated protein kinase kinase 2-like; K04369 mitogen-activated protein kinase kinase 2 [EC: 2.7.12.2] [KO: K04369] [EC: 2.7.12.2] |
| LAMTOR3; late endosomal/lysosomal adaptor, MAPK and MTOR activator 3 [KO: K04370] |
| |
| |
| MKNK1; MAP kinase interacting serine/threonine kinase 1 [KO: K04372] [EC: 2.7.11.1] |
| MKNK2; MAP kinase interacting serine/threonine kinase 2 [KO: K04372] [EC: 2.7.11.1] |
| RPS6KA3; ribosomal protein S6 kinase, 90kDa, polypeptide 3 [KO: K04373] [EC: 2.7.11.1] |
| RPS6KA1; ribosomal protein S6 kinase, 90kDa, polypeptide 1 [KO: K04373] [EC: 2.7.11.1] |
| RPS6KA2; ribosomal protein S6 kinase, 90kDa, polypeptide 2 [KO: K04373] [EC: 2.7.11.1] |
| RPS6KA6; ribosomal protein S6 kinase, 90kDa, polypeptide 6 [KO: K04373] [EC: 2.7.11.1] |
| ATF4; activating transcription factor 4 (tax-responsive enhancer element B67) [KO: K04374] |
| ELK1; ELK1, member of ETS oncogene family [KO: K04375] |
| ELK4; ELK4, ETS-domain protein (SRF accessory protein 1) [KO: K04376] |
| MYC; v-myc myelocytomatosis viral oncogene homolog (avian) [KO: K04377] |
| SRF; serum response factor (c-fos serum response element-binding transcription factor) [KO: K04378] |
| FOS; FBJ murine osteosarcoma viral oncogene homolog [KO: K04379] |
| MAPT; microtubule-associated protein tau [KO: K04380] |
| |
| |
| PLA2G4A; phospholipase A2, group IVA (cytosolic, calcium-dependent) [KO: K16342] [EC: 3.1.1.4] |
| cytosolic phospholipase A2 beta-like; K16342 cytosolic phospholipase A2 [EC: 3.1.1.4] [KO: K16342] [EC: 3.1.1.4] |
| PLA2G4B; phospholipase A2, group IVB (cytosolic) [KO: K16342] [EC: 3.1.1.4] |
| PLA2G4C; phospholipase A2, group IVC (cytosolic, calcium-independent) [KO: K16342] [EC: 3.1.1.4] |
| PLA2G4D; phospholipase A2, group IVD (cytosolic) [KO: K16342] [EC: 3.1.1.4] |
| |
| |
| |
| |
| |
| |
| TNF; tumor necrosis factor [KO: K03156] |
| IL1A; interleukin 1, alpha [KO: K04383] |
| IL1B; interleukin 1, beta [KO: K04519] |
| TGFB1; transforming growth factor, beta 1 [KO: K13375] |
| TGFB2; transforming growth factor, beta 2 [KO: K13376] |
| TGFB3; transforming growth factor, beta 3 [KO: K13377] |
| TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A [KO: K03158] |
| IL1R1; interleukin 1 receptor, type I [KO: K04386] |
| IL1R2; interleukin 1 receptor, type II [KO: K04387] |
| TGFBR1; transforming growth factor, beta receptor 1 [KO: K04674] [EC: 2.7.11.30] |
| TGFBR2; transforming growth factor, beta receptor II (70/80kDa) [KO: K04388] [EC: 2.7.11.30] |
| FASLG; Fas ligand (TNF superfamily, member 6) [KO: K04389] |
| FAS; Fas (TNF receptor superfamily, member 6) [KO: K04390] |
| CD14; CD14 molecule [KO: K04391] |
| RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO: K04392] |
| RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) [KO: K07860] |
| uncharacterized LOC747131; K07861 Ras-related C3 botulinum toxin substrate 3 [KO: K07861] |
| cell division control protein 42 homolog; K04393 cell division control protein 42 [KO: K04393] |
| CDC42; cell division cycle 42 (GTP binding protein, 25kDa) [KO: K04393] |
| CASP3; caspase 3, apoptosis-related cysteine peptidase [KO: K02187] [EC: 3.4.22.56] |
| TRAF2; TNF receptor-associated factor 2 [KO: K03173] |
| DAXX; death-domain associated protein [KO: K02308] |
| TRAF6; TNF receptor-associated factor 6, E3 ubiquitin protein ligase [KO: K03175] |
| GADD45G; growth arrest and DNA-damage-inducible, gamma [KO: K04402] |
| GADD45B; growth arrest and DNA-damage-inducible, beta [KO: K04402] |
| GADD45A; growth arrest and DNA-damage-inducible, alpha [KO: K04402] |
| TAB1; TGF-beta activated kinase 1/MAP3K7 binding protein 1 [KO: K04403] |
| TAB2; TGF-beta activated kinase 1/MAP3K7 binding protein 2 [KO: K04404] |
| ECSIT; ECSIT homolog (Drosophila) [KO: K04405] |
| MAP4K3; mitogen-activated protein kinase kinase kinase kinase 3 [KO: K04406] [EC: 2.7.11.1] |
| MAP4K4; mitogen-activated protein kinase kinase kinase kinase 4 [KO: K04407] [EC: 2.7.11.1] |
| MAP4K1; mitogen-activated protein kinase kinase kinase kinase 1 [KO: K04408] [EC: 2.7.11.1] |
| PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 [KO: K04409] [EC: 2.7.11.1] |
| PAK2; p21 protein (Cdc42/Rac)-activated kinase 2 [KO: K04410] [EC: 2.7.11.1] |
| STK4; serine/threonine kinase 4 [KO: K04411] |
| STK3; serine/threonine kinase 3 [KO: K04412] |
| MAP4K2; mitogen-activated protein kinase kinase kinase kinase 2 [KO: K04414] [EC: 2.7.11.1] |
| MAP3K8; mitogen-activated protein kinase kinase kinase 8 [KO: K04415] [EC: 2.7.11.25] |
| MAP3K1; mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase [KO: K04416] [EC: 2.7.11.25] |
| MAP3K11; mitogen-activated protein kinase kinase kinase 11 [KO: K04419] [EC: 2.7.11.25] |
| MAP3K2; mitogen-activated protein kinase kinase kinase 2 [KO: K04420] [EC: 2.7.11.25] |
| MAP3K3; mitogen-activated protein kinase kinase kinase 3 [KO: K04421] [EC: 2.7.11.25] |
| MAP3K13; mitogen-activated protein kinase kinase kinase 13 [KO: K04422] [EC: 2.7.11.25] |
| MAP3K12; mitogen-activated protein kinase kinase kinase 12 [KO: K04423] [EC: 2.7.11.25] |
| mitogen-activated protein kinase kinase kinase MLT-like; K04424 sterile alpha motif and leucine zipper containing kinase AZK [EC: 2.7.11.25] [KO: K04424] [EC: 2.7.11.25] |
| MAP3K6; mitogen-activated protein kinase kinase kinase 6 [KO: K04425] [EC: 2.7.11.25] |
| MAP3K5; mitogen-activated protein kinase kinase kinase 5 [KO: K04426] [EC: 2.7.11.25] |
| MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO: K04427] [EC: 2.7.11.25] |
| MAP3K4; mitogen-activated protein kinase kinase kinase 4 [KO: K04428] [EC: 2.7.11.25] |
| |
| |
| |
| MAP2K4; mitogen-activated protein kinase kinase 4 [KO: K04430] [EC: 2.7.12.2] |
| MAP2K7; mitogen-activated protein kinase kinase 7 [KO: K04431] [EC: 2.7.12.2] |
| dual specificity mitogen-activated protein kinase kinase 3-like; K04432 mitogen-activated protein kinase kinase 3 [EC: 2.7.12.2] [KO: K04432] [EC: 2.7.12.2] |
| MAP2K3; mitogen-activated protein kinase kinase 3 [KO: K04432] [EC: 2.7.12.2] |
| MAP2K6; mitogen-activated protein kinase kinase 6 [KO: K04433] [EC: 2.7.12.2] |
| MAPK8IP1; mitogen-activated protein kinase 8 interacting protein 1 [KO: K04434] |
| MAPK8IP2; mitogen-activated protein kinase 8 interacting protein 2 [KO: K04435] |
| MAPK8IP3; mitogen-activated protein kinase 8 interacting protein 3 [KO: K04436] |
| FLNB; filamin B, beta [KO: K04437] |
| FLNC; filamin C, gamma [KO: K04437] |
| CRKL; v-crk sarcoma virus CT10 oncogene homolog (avian)-like [KO: K04438] |
| CRK; v-crk sarcoma virus CT10 oncogene homolog (avian) [KO: K04438] |
| ARRB2; arrestin, beta 2 [KO: K04439] |
| ARRB1; arrestin, beta 1 [KO: K04439] |
| |
| |
| |
| |
| |
| |
| MAPKAPK5; mitogen-activated protein kinase-activated protein kinase 5 [KO: K04442] [EC: 2.7.11.1] |
| MAPKAPK2; mitogen-activated protein kinase-activated protein kinase 2 [KO: K04443] [EC: 2.7.11.1] |
| MAPKAPK3; mitogen-activated protein kinase-activated protein kinase 3 [KO: K04444] [EC: 2.7.11.1] |
| RPS6KA5; ribosomal protein S6 kinase, 90kDa, polypeptide 5 [KO: K04445] [EC: 2.7.11.1] |
| RPS6KA4; ribosomal protein S6 kinase, 90kDa, polypeptide 4 [KO: K16510] [EC: 2.7.11.1] |
| CDC25B; cell division cycle 25 homolog B (S. pombe) [KO: K05866] [EC: 3.1.3.48] |
| JUN; jun proto-oncogene [KO: K04448] |
| ATF2; activating transcription factor 2 [KO: K04450] |
| ATF2; activating transcription factor 2 [KO: K04450] |
| TP53; tumor protein p53 [KO: K04451] |
| DDIT3; DNA-damage-inducible transcript 3 [KO: K04452] |
| MAX; MYC associated factor X [KO: K04453] |
| MEF2C; myocyte enhancer factor 2C [KO: K04454] |
| HSPB1; heat shock 27kDa protein 1 [KO: K04455] |
| AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO: K04456] [EC: 2.7.11.1] |
| AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO: K04456] [EC: 2.7.11.1] |
| AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) [KO: K04456] [EC: 2.7.11.1] |
| PPM1A; protein phosphatase, Mg2+/Mn2+ dependent, 1A [KO: K04457] [EC: 3.1.3.16] |
| PTPRR; protein tyrosine phosphatase, receptor type, R [KO: K04458] [EC: 3.1.3.48] |
| PTPN7; protein tyrosine phosphatase, non-receptor type 7 [KO: K04458] [EC: 3.1.3.48] |
| PTPN5; protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) [KO: K04458] [EC: 3.1.3.48] |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| PPP5C; protein phosphatase 5, catalytic subunit [KO: K04460] [EC: 3.1.3.16] |
| PPM1B; protein phosphatase, Mg2+/Mn2+ dependent, 1B [KO: K04461] [EC: 3.1.3.16] |
| HSPA2; heat shock 70kDa protein 2 [KO: K03283] |
| HSPA1L; heat shock 70kDa protein 1-like [KO: K03283] |
| HSPA8; heat shock 70kDa protein 8 [KO: K03283] |
| HSPA1A; heat shock 70kDa protein 1A [KO: K03283] |
| MECOM; MDS1 and EVI1 complex locus [KO: K04462] |
| MAP2K5; mitogen-activated protein kinase kinase 5 [KO: K04463] [EC: 2.7.12.2] |
| |
| NR4A1; nuclear receptor subfamily 4, group A, member 1 [KO: K04465] |
| MAP3K14; mitogen-activated protein kinase kinase kinase 14 [KO: K04466] [EC: 2.7.11.25] |
| CHUK; conserved helix-loop-helix ubiquitous kinase [KO: K04467] [EC: 2.7.11.10] |
| IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO: K07209] [EC: 2.7.11.10] |
| NF-kappa-B essential modulator-like; K07210 inhibitor of nuclear factor kappa-B kinase subunit gamma [KO: K07210] |
| |
| NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO: K02580] |
| NFKB2; nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) [KO: K04469] |
| RELA; v-rel reticuloendotheliosis viral oncogene homolog A (avian) [KO: K04735] |
| RELB; v-rel reticuloendotheliosis viral oncogene homolog B [KO: K09253] |
| NFATC4; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 [KO: K04446] |
| NFATC2; nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 [KO: K04446] |